These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26970965)

  • 41. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.
    De Roock W; De Vriendt V; Normanno N; Ciardiello F; Tejpar S
    Lancet Oncol; 2011 Jun; 12(6):594-603. PubMed ID: 21163703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib.
    Hoogstraat M; Gadellaa-van Hooijdonk CG; Ubink I; Besselink NJ; Pieterse M; Veldhuis W; van Stralen M; Meijer EF; Willems SM; Hadders MA; Kuilman T; Krijgsman O; Peeper DS; Koudijs MJ; Cuppen E; Voest EE; Lolkema MP
    Pigment Cell Melanoma Res; 2015 May; 28(3):318-23. PubMed ID: 25515853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic alterations in main candidate genes during melanoma progression.
    Sini MC; Doneddu V; Paliogiannis P; Casula M; Colombino M; Manca A; Botti G; Ascierto PA; Lissia A; Cossu A; Palmieri G
    Oncotarget; 2018 Feb; 9(9):8531-8541. PubMed ID: 29492214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Driver mutations in melanoma: lessons learned from bench-to-bedside studies.
    Mehnert JM; Kluger HM
    Curr Oncol Rep; 2012 Oct; 14(5):449-57. PubMed ID: 22723080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations.
    Davidson G; Coassolo S; Kieny A; Ennen M; Pencreach E; Malouf GG; Lipsker D; Davidson I
    J Invest Dermatol; 2019 Aug; 139(8):1769-1778.e2. PubMed ID: 30776432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PTEN Methylation Dependent Sinonasal Mucosal Melanoma.
    Lee SH; Roh MR; Kang B; Park KH; Kim SH; Lee SE; Rha SY
    Cancer Res Treat; 2016 Apr; 48(2):853-8. PubMed ID: 25797573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic mutations involved in melanoma: a summary of our current understanding.
    High WA; Robinson WA
    Adv Dermatol; 2007; 23():61-79. PubMed ID: 18159896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The RAC1 Target NCKAP1 Plays a Crucial Role in the Progression of Braf;Pten-Driven Melanoma in Mice.
    Swaminathan K; Campbell A; Papalazarou V; Jaber-Hijazi F; Nixon C; McGhee E; Strathdee D; Sansom OJ; Machesky LM
    J Invest Dermatol; 2021 Mar; 141(3):628-637.e15. PubMed ID: 32777214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.
    Rossi E; Schinzari G; Maiorano BA; Pagliara MM; Di Stefani A; Bria E; Peris K; Blasi MA; Tortora G
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival.
    Ferguson J; Wilcock DJ; McEntegart S; Badrock AP; Levesque M; Dummer R; Wellbrock C; Smith MP
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):74-85. PubMed ID: 31323160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptional regulators and alterations that drive melanoma initiation and progression.
    Gupta R; Janostiak R; Wajapeyee N
    Oncogene; 2020 Nov; 39(48):7093-7105. PubMed ID: 33024276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiregional Sequencing Reveals Genomic Alterations and Clonal Dynamics in Primary Malignant Melanoma of the Esophagus.
    Li J; Yan S; Liu Z; Zhou Y; Pan Y; Yuan W; Liu M; Tan Q; Tian G; Dong B; Cai H; Wu N; Ke Y
    Cancer Res; 2018 Jan; 78(2):338-347. PubMed ID: 28972077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma.
    Doma V; Kárpáti S; Rásó E; Barbai T; Tímár J
    BMC Cancer; 2019 Aug; 19(1):786. PubMed ID: 31391014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastatic melanoma treatment: Combining old and new therapies.
    Davey RJ; van der Westhuizen A; Bowden NA
    Crit Rev Oncol Hematol; 2016 Feb; 98():242-53. PubMed ID: 26616525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Main roads to melanoma.
    Palmieri G; Capone M; Ascierto ML; Gentilcore G; Stroncek DF; Casula M; Sini MC; Palla M; Mozzillo N; Ascierto PA
    J Transl Med; 2009 Oct; 7():86. PubMed ID: 19828018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melanoma Regression and Recurrence in Zebrafish.
    Wojciechowska S; Zeng Z; Lister JA; Ceol CJ; Patton EE
    Methods Mol Biol; 2016; 1451():143-53. PubMed ID: 27464806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma.
    Guan J; Gupta R; Filipp FV
    Sci Rep; 2015 Jan; 5():7857. PubMed ID: 25600636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biology of Melanoma.
    Ostrowski SM; Fisher DE
    Hematol Oncol Clin North Am; 2021 Feb; 35(1):29-56. PubMed ID: 33759772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melanoma: from mutations to medicine.
    Tsao H; Chin L; Garraway LA; Fisher DE
    Genes Dev; 2012 Jun; 26(11):1131-55. PubMed ID: 22661227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases.
    Li Y; Pan W; Connolly ID; Reddy S; Nagpal S; Quake S; Gephart MH
    J Neurooncol; 2016 May; 128(1):93-100. PubMed ID: 26961773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.